WBRT prior to or concurrently with chemotherapy improved iPFS and OS in NSCLC patients who were EGFR, ALK, and PD-L1 negative, had an ECOG PS of 2, and had multiple metastases including brain metastases. The gene discussed is CD274; the disease is non-small cell lung carcinoma.